biblio

Filters: Author is Dinulescu, Daniela M.  [Clear All Filters]
2010
A. S. Paraskar, Soni, S., Chin, K. T., Chaudhuri, P., Muto, K. W., Berkowitz, J., Handlogten, M. W., Alves, N. J., Bilgicer, B., Dinulescu, D. M., Mashelkar, R. Anant, and Sengupta, S., “Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy”, Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 28, pp. 12435-12440, 2010.
2012
P. Sengupta, Basu, S., Soni, S., Pandey, A., Roy, B., Oh, M. S., Chin, K. T., Paraskar, A. S., Sarangi, S., Connor, Y., Sabbisetti, V. S., Kopparam, J., Kulkarni, A., Muto, K., Amarasiriwardena, C., Jayawardene, I., Lupoli, N., Dinulescu, D. M., Bonventre, J. V., Mashelkar, R. Anant, and Sengupta, S., “Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity”, Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 28, pp. 11294-11299, 2012.
2013
A. A. Kulkarni, Roy, B., Rao, P. S., Wyant, G. A., Mahmoud, A., Ramachandran, M., Sengupta, P., Goldman, A., Kotamraju, V. Ramana, Basu, S., Mashelkar, R. Anant, Ruoslahti, E., Dinulescu, D. M., and Sengupta, S., “Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy”, Cancer Research, vol. 73, no. 23, pp. 6987-6997, 2013.